Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3334569 | Surgical Pathology Clinics | 2014 | 12 Pages |
Abstract
Urothelial carcinoma (UC) is the most common malignancy of the urinary tract. Cytology and cystoscopy are two of the most commonly used tests for screening and diagnosis of UC. However, the sensitivity of cytology for UC is less than ideal, while cystoscopy is an invasive and expensive procedure. The search for an accurate, sensitive, noninvasive, and cost-effective method for detecting UC has led to the development of ancillary studies using immunological and molecular methods.
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
Amy G. Zhou, Lloyd M. Hutchinson, Ediz F. Cosar,